Related Experiment Video
Updated: Jun 25, 2026

A Multi-Modal Approach to Assessing Recovery in Youth Athletes Following Concussion
Published on: September 25, 2014
A multi-site Canadian perspective: examining the functional outcome from first-episode psychosis
N M Menezes1, A M Malla, R M Norman
1Schizophrenia Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. menezes@mcmaster.ca
First-episode psychosis (FEP) patients achieve high symptomatic remission but lower functional recovery after one year. Ongoing symptoms and substance abuse significantly impact functional outcomes in FEP.
Area of Science:
- Psychiatry
- Clinical Psychology
- Neuroscience
Background:
- First-episode psychosis (FEP) represents a critical stage in the illness trajectory.
- Understanding factors influencing functional recovery is crucial for effective treatment.
Purpose of the Study:
- To identify predictors of functional outcome variance in FEP patients after one year of treatment.
- To differentiate between symptomatic remission and functional recovery rates.
Main Methods:
- A naturalistic 1-year follow-up study of 200 FEP patients across four university centers.
- Functional recovery defined by Social and Occupational Functioning Assessment Scale (SOFAS) score > 60.
- Regression analysis to determine factors contributing to outcome variance.
Main Results:
- Functional recovery was achieved by 51% of patients, contrasted with 74% achieving symptomatic remission.
- Ongoing symptoms at 6 months and comorbid substance abuse were the primary contributors to outcome variance.
- 70% of patients were engaged in school/work and satisfactory relationships at 12 months.
Conclusions:
- FEP treatment yields high symptomatic remission but lags in functional recovery.
- Persistent symptoms and substance abuse are key targets for improving functional outcomes in FEP.
- Early intervention focusing on symptom management and substance use is vital for enhancing long-term functional recovery.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Schizophrenia
Psychological and Sociocultural Causes of Schizophrenia
